Pharmaceutical company intelligence

Winlet Pharmaceuticals (Pvt) Ltd.

Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.

Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view

Rx117product presentations

G45generic molecules

DF6dosage-form groups

TA4therapeutic areas

PKR117current price records

REG92registration numbers

Data coverage

How complete is this profile?

Current price coverage100%

products with a current official price

Source-linked coverage100%

products linked back to a source record

Unit-price parse coverage99%

priced packs safely normalized per unit

Comparable-market coverage93%

products with at least one like-for-like comparator

Portfolio intelligence

Therapeutic mix

Unclassified110 products · 94%

Third-generation cephalosporins3 products · 3%

Fluoroquinolone antibacterials2 products · 2%

Angiotensin II receptor blockers1 products · 1%

Proton pump inhibitors1 products · 1%

Formulation footprint

Dosage forms

Tablet50 products

Suspension21 products

Capsule17 products

Injection14 products

Syrup13 products

Infusion2 products

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales

#1 OnsoftOndansetron 8presentations 4 mg, 4 mg/5 mL, 8 mg, 8 mg/4 mL · Tablet, Syrup, Injection #2 AntileptLevetiracetam 6presentations 100 mg/mL, 250 mg, 500 mg · Syrup, Tablet #3 MacrowinAzithromycin 6presentations 200 mg/5 mL, 250 mg, 500 mg · Suspension, Capsule, Tablet #4 ClarletClarithromycin 4presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #5 LinzoletLinezolid 4presentations 100 mg/5 mL, 600 mg, 600 mg/300 mL · Suspension, Tablet, Infusion #6 RicoletVoriconazole 4presentations 200 mg, 200 mg/5 mL, 50 mg · Tablet, Suspension

Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis

Below market median3633% of comparable products

Near market median52within ±5% of median

Above market median2119% of comparable products

Lowest-price equivalents8ties included

Company median price position -1.7% relative to the median unit price of like-for-like equivalent products.

Most competitively positioned examplesProducts with at least 3 market comparators

Vincip 125 mg/5 mLCiprofloxacin · Dry suspension · 120ml PKR 2.02/mL-42.9% vs market median PTB 2 g + 0.25 gPiperacillin + tazobactam · Injection · 1 Vial PKR 418.37/vial/unit-41.2% vs market median PTB 4 g + 0.5 gPiperacillin + tazobactam · Injection · 1 Vial PKR 951.18/vial/unit-38.3% vs market median Ricolet 200 mg/5 mLVoriconazole · Dry suspension · 75ml PKR 25.68/mL-33.4% vs market median Ricolet 200 mg/5 mLVoriconazole · Dry suspension · 60ml PKR 27.07/mL-29.7% vs market median

How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,362 products · 118 generics 28shared generics Pharmasol (Pvt) Ltd.251 products · 101 generics 27shared generics Mediate Pharmaceutical Pvt Ltd239 products · 90 generics 26shared generics M/s. Genix Pharma (Pvt) Ltd.290 products · 97 generics 25shared generics CCL Pharmaceuticals (Pvt.) Ltd.243 products · 90 generics 25shared generics De-Mont Research Laboratories (Pvt.) Ltd.88 products · 44 generics 25shared generics

Regulatory & price activity

Observed database signals

Registration numbers92

Price-history records142

Products with price history23

Source records with multiple versions0

Latest MedInfoBase verification9 Aug 2026

Latest effective price date1 Jul 2025

Latest source observation9 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed

Complete company portfolio

Products and presentations

117 results

Brand	Generic	Strength	Form	Pack	Registration	Official price	Unit price	Market position
Taxa	Tranexamic acid	250 mg	Capsule	100'S	104838	PKR 1,480.90	PKR 14.81/capsule	39% above median
Taxa	Tranexamic acid	250 mg	Capsule	20'S	104838	PKR 296.18	PKR 14.81/capsule	39% above median
Telecef	Ceftriaxone	250 mg	Injection	1 Vial	104810	PKR 192.73	PKR 192.73/vial/unit	Near median
Telecef	Ceftriaxone	500 mg	Injection	1 Vial	104811	PKR 324.39	PKR 324.39/vial/unit	Near median
Telecef	Ceftriaxone	1 g	Injection	1 Vial	104812	PKR 612.52	PKR 612.52/vial/unit	Near median
Tymadol 37.5	Tramadol + Paracetamol	37.5 mg + 325 mg	Tablet	10'S	092049	PKR 208.86	PKR 20.89/tablet	10% above median
Tymadol 37.5	Tramadol + Paracetamol	37.5 mg + 325 mg	Tablet	20'S	092049	PKR 409.35	PKR 20.47/tablet	7% above median
Vincip	Ciprofloxacin	250 mg/5 mL	Dry suspension	60ml	100640	PKR 286.97	PKR 4.78/mL	Near median
Vincip	Ciprofloxacin	125 mg/5 mL	Dry suspension	60ml	100641	PKR 161.42	PKR 2.69/mL	24% below median
Vincip	Ciprofloxacin	250 mg/5 mL	Dry suspension	120ml	100640	PKR 430.46	PKR 3.59/mL	27% below median
Vincip	Ciprofloxacin	125 mg/5 mL	Dry suspension	120ml	100641	PKR 242.14	PKR 2.02/mL	43% below median
Winret	Loratadine	5 mg/5 mL	Syrup	60ml	107048	PKR 93.50	PKR 1.56/mL	7% below median
Wintat	Fluvastatin	40 mg	Capsule	10'S	107993	PKR 410.10	PKR 41.01/capsule	13% above median
Wintat	Fluvastatin	20 mg	Capsule	10'S	107998	PKR 296.18	PKR 29.62/capsule	13% above median
Wintine	Fluoxetine	20 mg	Capsule	10'S	107999	PKR 124.03	PKR 12.40/capsule	Near median
Zingut	Zinc	20 mg/5 mL	Syrup	120ml	092026	PKR 215.23	PKR 1.79/mL	Near median
Zingut	Zinc	20 mg/5 mL	Syrup	60ml	092026	PKR 107.62	PKR 1.79/mL	Near median

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.